Medical Devices Investors & VC Firms

1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
JS JSD Capital, LLC JMJSAHGM8 people	88🔒	New York	US	Seed–Late Stage	$10M	+ Add to CRM
EL Elmehøj Ventures AR1 person · Follows rounds	88🔒	Copenhagen	DK	Pre-Seed–Series A	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Seed–Late Stage	$5M – $15M	+ Add to CRM
AP Applied Ventures AHKEBGBM13 people	88🔒	Santa Clara	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
AV Avant Bio DKSLLUMW7 people · Leads rounds	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
EX ExSight Ventures JCFMMNRC4 people	88🔒	—		Pre-Seed–Series B	—	+ Add to CRM
PA Pappas Capital APEKSWTM7 people	88🔒	Research Triangle Park	US	Seed–Late Stage	$100K – $6M	+ Add to CRM
BL BlueOcean Ventures EDFSSHTZ6 people · Leads rounds	88🔒	Geneva	CH	Pre-Seed–Series A	$270K – $1.4M	+ Add to CRM
KE Kendall Capital Partners DZDRGMRS6 people	88🔒	Boston	US	Seed–Growth	—	+ Add to CRM
LO Longwall Venture Partners LLP DDJBMFMP6 people · Leads rounds	88🔒	Harwell	GB	Seed–Series A	$2M	+ Add to CRM
VE Vertex Ventures HC CBLHYLAC6 people	88🔒	Singapore	SG	Seed–Growth	$500K – $10M	+ Add to CRM
AL Altium Capital JGJTALDW5 people	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
CU Curie Capital HDMVOTHV8 people · Leads rounds	88🔒	Amsterdam	NL	Seed–Series A	—	+ Add to CRM
IN Investo Capital JJHLJMTB5 people · Follows rounds	88🔒	Aalborg	DK	Pre-Seed–Series A	$30K – $3M	+ Add to CRM
CW CWRU Technology Ventures DP1 person	88🔒	Cleveland	US	Pre-Seed–Seed	$50K – $250K	+ Add to CRM
FO Fox Ventures PBAMABDF7 people	88🔒	Champaign	US	Seed–Late Stage	$50K – $250K	+ Add to CRM
NE Newlin Investment Company LLC WRSNCAWR4 people	88🔒	Pittsburgh	US	Seed–Growth	$100K – $3M	+ Add to CRM
OW Owl Rock Capital CPDOMLMM4 people · Leads rounds	88🔒	New York	US	Growth–Late Stage	$20M – $250M	+ Add to CRM
AV Aviv Venture Capital AGSCYZ3 people	88🔒	Tel Aviv	IL	Seed–Series A	—	+ Add to CRM
DF DFJ DragonFund	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
IN Inclusion Japan Leads rounds	88🔒	—	JP	Pre-Seed–Growth	—	+ Add to CRM
NA Nanopoulos & Partners Family Office KNNDVICH9 people	88🔒	Athens	GR	—	—	+ Add to CRM
UN Unfold Ventures JSAJMSJS6 people	88🔒	Wrocław	PL	Pre-Seed–Late Stage	$110K – $1.1M	+ Add to CRM
WA Wallonie Entreprendre BLCFGLMB9 people	88🔒	Liège	BE	Pre-Seed–Late Stage	—	+ Add to CRM

JSD Capital, LLC

New YorkSeed–Late Stage$10M

JMJSAHGM8 people

Elmehøj Ventures

CopenhagenPre-Seed–Series A

AR1 person

Kern Capital, LLC

LarkspurSeed–Late Stage$5M – $15M

JK1 person

Applied Ventures

Santa ClaraSeed–Late Stage$500K – $3M

AHKEBGBM13 people

Avant Bio

New YorkSeed–Growth

DKSLLUMW7 people

ExSight Ventures

Pre-Seed–Series B

JCFMMNRC4 people

Pappas Capital

Research Triangle ParkSeed–Late Stage$100K – $6M

APEKSWTM7 people

BlueOcean Ventures

GenevaPre-Seed–Series A$270K – $1.4M

EDFSSHTZ6 people

Kendall Capital Partners

BostonSeed–Growth

DZDRGMRS6 people

Longwall Venture Partners LLP

HarwellSeed–Series A$2M

DDJBMFMP6 people

Vertex Ventures HC

SingaporeSeed–Growth$500K – $10M

CBLHYLAC6 people

Altium Capital

New YorkSeed–Growth

JGJTALDW5 people

Curie Capital

AmsterdamSeed–Series A

HDMVOTHV8 people

Investo Capital

AalborgPre-Seed–Series A$30K – $3M

JJHLJMTB5 people

CWRU Technology Ventures

ClevelandPre-Seed–Seed$50K – $250K

DP1 person

Fox Ventures

ChampaignSeed–Late Stage$50K – $250K

PBAMABDF7 people

Newlin Investment Company LLC

PittsburghSeed–Growth$100K – $3M

WRSNCAWR4 people

Owl Rock Capital

New YorkGrowth–Late Stage$20M – $250M

CPDOMLMM4 people

Aviv Venture Capital

Tel AvivSeed–Series A

AGSCYZ3 people

DFJ DragonFund

ShanghaiSeed–Late Stage

Inclusion Japan

Pre-Seed–Growth

Nanopoulos & Partners Family Office

Athens

KNNDVICH9 people

Unfold Ventures

WrocławPre-Seed–Late Stage$110K – $1.1M

JSAJMSJS6 people

Wallonie Entreprendre

LiègePre-Seed–Late Stage

BLCFGLMB9 people

Data sourced from public filings and firms' own websites — see our methodology.